For research use only. Not for therapeutic Use.
Ublituximab（Cat No.:I042128）is a monoclonal antibody that targets CD20, a protein found on the surface of B-cells. By binding to CD20, ublituximab helps eliminate malignant B-cells, making it particularly useful in treating B-cell-related disorders like non-Hodgkin lymphoma and chronic lymphocytic leukemia (CLL). It also shows promise in treating multiple sclerosis (MS) by depleting B-cells involved in the autoimmune process. Ublituximab has demonstrated effectiveness in clinical trials, and it is often used in combination with other therapies to improve outcomes for patients with these conditions.
| Catalog Number | I042128 |
| CAS Number | 1174014-05-1 |
| Purity | ≥95% |
